Home/Filings/4/0001104659-19-020731
4//SEC Filing

NISSEN TORBEN STRAIGHT 4

Accession 0001104659-19-020731

CIK 0001709401other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 9:44 PM ET

Size

5.2 KB

Accession

0001104659-19-020731

Insider Transaction Report

Form 4
Period: 2019-04-08
Transactions
  • Sale

    Common Stock

    2019-04-08$20.00/sh2,100$42,0001,845,304 total
Footnotes (2)
  • [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The Reporting Person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Rubius Therapeutics, Inc.

CIK 0001709401

Entity typeother

Related Parties

1
  • filerCIK 0001746647

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:44 PM ET
Size
5.2 KB